MedPath

NORTHWIND PHARMACEUTICALS, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

458

FDA:458

Drug Approvals

Doxazosin

Approval Date
Feb 28, 2024
FDA

Pantoprazole Sodium

Approval Date
Feb 23, 2024
FDA

hydroxyzine pamoate

Approval Date
Feb 19, 2024
FDA

Glipizide

Approval Date
Feb 15, 2024
FDA

Omeprazole

Approval Date
Feb 15, 2024
FDA

Hydralazine Hydrochloride

Approval Date
Feb 15, 2024
FDA

nitrofurantoin macrocrystals

Approval Date
Feb 8, 2024
FDA

Bupropion Hydrochloride

Approval Date
Feb 8, 2024
FDA

Prochlorperazine Maleate

Approval Date
Feb 6, 2024
FDA

Estradiol

Approval Date
Feb 5, 2024
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 46
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy